Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
A16AB10
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
velaglucerase alfa
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vpriv
|
| gptkbp:indication |
long-term enzyme replacement therapy in patients with type 1 Gaucher disease
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
dizziness fatigue headache hypertension back pain joint pain infusion-related reactions |
| gptkbp:usedFor |
gptkb:Gaucher_disease_type_1
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|